市場調査レポート

商品コード

1529715

人工多能性幹細胞生産の市場規模、シェア、動向分析レポート：プロセス別、ワークフロー別、製品別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: 2024年07月09日 | 発行: Grand View Research

| ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 5,950 911,302円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,064,462円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,370,782円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=153.16円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

人工多能性幹細胞生産市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界の人工多能性幹細胞生産市場規模は、2024～2030年にかけてCAGR 9.44％を記録し、2030年までに27億6,000万米ドルに達すると予測されています。

胚性幹細胞（ESC）と比較して人工多能性幹細胞（iPSC）の需要が増加していることが市場を大きく牽引しています。幹細胞に関連する倫理的問題がないこと、個別化治療が可能であること、細胞を用いた研究において柔軟性があることなどの利点が、市場成長にとって有利なシナリオを生み出しています。加えて、慢性疾患の流行も人工多能性幹細胞生産市場の成長を後押ししています。というのも、心臓病、脳卒中、糖尿病、その他多くの疾患は、iPS細胞を介した治療を利用することで治療できるからです。例えば、国際糖尿病連合（IDF）によると、2021年にはすでに5億3,700万人が糖尿病を患っているといいます。

COVID-19パンデミック時の研究活動の高まりは、市場にプラスの影響を与えています。パンデミックは、SARS CoV-2感染によって患者に多くの疾患が発生したため、多くのセグメントで研究を促進しました。例えば、2021年4月、米国の研究者たちは、COVID-19患者の最大25％が心機能障害に苦しんでいると述べた。研究論文を通じて、彼らはiPS細胞由来の心臓細胞をSARS CoV-2に暴露することで発症することを証明し、患者のヒト剖検標本からも同様の変化が確認されました。このような洞察により、人工多能性幹細胞（iPSC）を薬剤や治療法の開発プラットフォームとして利用し、COVID-19の長期的影響の管理に活用することが可能になります。

人工多能性幹細胞は、成人の体細胞から誘導され、さらにESCのような多能性を獲得するように再プログラムされた細胞です。このiPS細胞は、ESCを使用する調査にとって、倫理的に問題のない選択肢であることが証明されつつあります。ESCの作製は胚盤胞の段階で胚を破壊することになるため、倫理的な議論が最大になります。しかし、人工多能性幹細胞は、体細胞の遺伝子初期化のみを行うことで、研究におけるヒト胚の破壊に関する倫理的問題を解決しました。このことが市場の成長を促進し、創薬、疾患モデリング、毒性試験など数多くの応用をもたらしました。例えば、2021年8月、Fate Therapeuticsは、臨床試験中のFT819による最初の患者の治療を発表しました。FT819はiPS細胞由来の人工CAR-T細胞療法です。また、分化可能性、自己再生可能性、免疫調節特性などのユニークな特性により、再生医療における人工多能性幹細胞の応用を模索する研究コミュニティーの注目度が高まっていることも、市場拡大の原動力となっています。

人工多能性幹細胞生産市場レポートハイライト

プロセス別では、手作業によるiPSC生産プロセスが市場を独占し、2023年に最大の収益シェアを占めました。
ワークフロー別では、細胞培養セグメントが市場を独占し、2023年に37.34%の最大収益シェアを占めました。細胞培養ワークフローには、iPSC採取製品、拡大製品、分化製品から得られる収益が含まれるため、このセグメントの市場関連性に寄与しています。
製品別では、消耗品とキットのセグメントが市場を独占し、2023年には40.32%の最大収益シェアを占めました。iPSCセグメントにおける絶え間ない研究開発活動が、さまざまな消耗品・キットの需要を牽引しています。
用途別では、医薬品開発・探索セグメントが2023年に43.33%の最大売上シェアで市場を独占しました。
最終用途別では、バイオテクノロジー・製薬企業セグメントが2023年に59.35%の最大収益シェアで市場を独占しました。iPSC製品とともに、さまざまなキット、消耗品、器具が入手可能であり、採用されていることが、このセグメントの収益創出を促進しています。
北米が市場を独占し、2023年には40.98%の最大収益シェアを占めました。この地域における慢性疾患の罹患率の増加、整備された医療インフラ、民間と政府のイニシアティブによる資金、戦略的ビジネスモデルが、この市場の収益創出を促進しています。

ワークフローセグメントダッシュボード
世界の人工多能性幹細胞生産市場のワークフロー変動分析
世界の人工多能性幹細胞生産市場規模と動向分析、ワークフロー別、2018～2030年
再プログラミング
細胞培養
細胞特性評価/分析
エンジニアリング
その他

第6章人工多能性幹細胞生産市場：製品ビジネス分析

製品セグメントダッシュボード
世界の人工多能性幹細胞生産市場の製品変動分析
世界の人工多能性幹細胞生産市場規模と動向分析、製品別、2018～2030年
機器/装置
自動化プラットフォーム
消耗品とキット
サービス

第7章人工多能性幹細胞生産市場：用途ビジネス分析

サンプルタイプセグメントダッシュボード
世界の人工多能性幹細胞生産市場の用途変動分析
世界の人工多能性幹細胞生産市場規模と動向分析、用途別、2018～2030年
医薬品の開発と発見
再生医療
毒性学研究
その他

第8章人工多能性幹細胞生産市場：最終用途ビジネス分析

最終用途セグメントダッシュボード
世界の人工多能性幹細胞生産市場の最終用途変動分析
世界の人工多能性幹細胞生産市場規模と動向分析、最終用途別、2018～2030年
研究・学術機関
バイオテクノロジーと製薬会社
病院・クリニック

第9章人工多能性幹細胞生産市場：プロセス、ワークフロー、製品、用途、最終用途別の地域推定・動向分析

地域ダッシュボード
市場規模と予測と動向分析、2018～2030年
北米
欧州
アジア太平洋
ラテンアメリカ
中東・アフリカ

第10章競合情勢

参入企業
戦略マッピング
企業市況分析、2023年
参入企業概要
- Lonza
- Axol Bioscience Ltd.
- Evotec
- REPROCELL Inc.
- STEMCELL Technologies
- Merck KGaA
- Fate Therapeutics
- Thermo Fisher Scientific, Inc.
- Catalent, Inc
- Applied StemCells, Inc.

第11章アナリストの視点

図表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 4 Global induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 5 Global induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 6 Global induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 7 Global induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 8 Global induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
Table 9 North America induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
Table 10 North America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 11 North America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 12 North America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 13 North America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 14 North America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 15 U.S. induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 16 U.S. induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 17 U.S. induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 18 U.S. induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 19 U.S. induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 20 Canada induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 21 Canada induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 22 Canada induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 23 Canada induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 24 Canada induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 25 Mexico induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 26 Mexico induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 27 Mexico induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 28 Mexico induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 29 Mexico induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 30 Europe induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
Table 31 Europe induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 32 Europe induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 33 Europe induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 34 Europe induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 35 Europe induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 36 UK induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 37 UK induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 38 UK induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 39 UK induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 40 UK induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 41 Germany induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 42 Germany induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 43 Germany induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 44 Germany induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 45 Germany induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 46 France induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 47 France induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 48 France induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 49 France induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 50 France induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 51 Italy induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 52 Italy induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 53 Italy induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 54 Italy induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 55 Italy induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 56 Spain induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 57 Spain induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 58 Spain induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 59 Spain induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 60 Spain induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 61 Denmark induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 62 Denmark induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 63 Denmark induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 64 Denmark induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 65 Denmark induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 66 Sweden induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 67 Sweden induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 68 Sweden induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 69 Sweden induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 70 Sweden induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 71 Norway induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 72 Norway induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 73 Norway induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 74 Norway induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 75 Norway induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 76 Asia Pacific induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
Table 77 Asia Pacific induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 78 Asia Pacific induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 79 Asia Pacific induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 80 Asia Pacific induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 81 Asia Pacific induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 82 Japan induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 83 Japan induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 84 Japan induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 85 Japan induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 86 Japan induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 87 China induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 88 China induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 89 China induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 90 China induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 91 China induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 92 India induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 93 India induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 94 India induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 95 India induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 96 India induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 97 Australia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 98 Australia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 99 Australia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 100 Australia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 101 Australia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 102 Thailand induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 103 Thailand induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 104 Thailand induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 105 Thailand induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 106 Thailand induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 107 South Korea induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 108 South Korea induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 109 South Korea induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 110 South Korea induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 111 South Korea induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 112 Latin America induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
Table 113 Latin America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 114 Latin America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 115 Latin America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 116 Latin America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 117 Latin America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 118 Brazil induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 119 Brazil induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 120 Brazil induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 121 Brazil induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 122 Brazil induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 123 Argentina induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 124 Argentina induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 125 Argentina induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 126 Argentina induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 127 Argentina induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 128 Middle East & Africa induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
Table 129 Middle East & Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 130 Middle East & Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 131 Middle East & Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 132 Middle East & Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 133 Middle East & Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 134 South Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 135 South Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 136 South Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 137 South Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 138 South Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 143 Saudi Arabia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 144 UAE induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 145 UAE induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 146 UAE induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 147 UAE induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 148 UAE induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 149 Kuwait induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 150 Kuwait induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 151 Kuwait induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 152 Kuwait induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 153 Kuwait induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 154 Participant's overview
Table 155 Financial performance
Table 156 Key companies undergoing expansions
Table 157 Key companies undergoing acquisitions
Table 158 Key companies undergoing collaborations
Table 159 Key companies launching new products
Table 160 Key companies undertaking other strategies

List of Figures

Fig. 1 Induced pluripotent stem cells production market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 Induced pluripotent stem cells production market driver analysis
Fig. 12 Induced pluripotent stem cells production market restraint analysis
Fig. 13 Induced pluripotent stem cells production market: Porter's analysis
Fig. 14 Induced pluripotent stem cells production market: PESTEL analysis
Fig. 15 Induced pluripotent stem cells production market: Product outlook and key takeaways
Fig. 16 Induced pluripotent stem cells production market: Product market share analysis, 2023 - 2030
Fig. 17 Global induced pluripotent stem cells production by instruments/devices market, 2018 - 2030 (USD Million)
Fig. 18 Global induced pluripotent stem cells production by automated platforms market, 2018 - 2030 (USD Million)
Fig. 19 Global induced pluripotent stem cells production by consumables & kits market, 2018 - 2030 (USD Million)
Fig. 20 Global induced pluripotent stem cells production by kits market, 2018 - 2030 (USD Million)
Fig. 21 Global induced pluripotent stem cells production by media market, 2018 - 2030 (USD Million)
Fig. 22 Global induced pluripotent stem cells production by others market, 2018 - 2030 (USD Million)
Fig. 23 Global induced pluripotent stem cells production by services market, 2018 - 2030 (USD Million)
Fig. 24 Induced pluripotent stem cells production market: Process outlook and key takeaways
Fig. 25 Induced pluripotent stem cells production market: Process market share analysis, 2023 - 2030
Fig. 26 Global induced pluripotent stem cells production by manual iPSC production process market, 2018 - 2030 (USD Million)
Fig. 27 Global induced pluripotent stem cells production by automated iPSC production process market, 2018 - 2030 (USD Million)
Fig. 28 Induced pluripotent stem cells production market: Workflow outlook and key takeaways
Fig. 29 Induced pluripotent stem cells production market: Workflow market share analysis, 2023 - 2030
Fig. 30 Global induced pluripotent stem cells production by reprogramming market, 2018 - 2030 (USD Million)
Fig. 31 Global induced pluripotent stem cells production by cell culture market, 2018 - 2030 (USD Million)
Fig. 32 Global induced pluripotent stem cells production by cell characterization/analysis market, 2018 - 2030 (USD Million)
Fig. 33 Global induced pluripotent stem cells production by engineering market, 2018 - 2030 (USD Million)
Fig. 34 Global induced pluripotent stem cells production by others market, 2018 - 2030 (USD Million)
Fig. 35 Induced pluripotent stem cells production market: Application outlook and key takeaways
Fig. 36 Induced pluripotent stem cells production market: Application market share analysis, 2023 - 2030
Fig. 37 Global induced pluripotent stem cells production by drug development & discovery market, 2018 - 2030 (USD Million)
Fig. 38 Global induced pluripotent stem cells production by regenerative medicine market, 2018 - 2030 (USD Million)
Fig. 39 Global induced pluripotent stem cells production by toxicology studies market, 2018 - 2030 (USD Million)
Fig. 40 Global induced pluripotent stem cells production by others market, 2018 - 2030 (USD Million)
Fig. 41 Induced pluripotent stem cells production market: End use outlook and key takeaways
Fig. 42 Induced pluripotent stem cells production market: End use market share analysis, 2023 - 2030
Fig. 43 Global induced pluripotent stem cells production by research & academic institutes market, 2018 - 2030 (USD Million)
Fig. 44 Global induced pluripotent stem cells production by biotechnology & pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 45 Global induced pluripotent stem cells production by hospitals & clinics market, 2018 - 2030 (USD Million)
Fig. 46 Regional marketplace: Key takeaways
Fig. 47 North America induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 U.S. induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Canada induced pluripotent stem cells production market, 2018 - 2030 (USD Million)
Fig. 50 Mexico induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Europe induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 UK induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Germany induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 France induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Italy induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Spain induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Denmark induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Sweden induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Norway induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Asia-Pacific induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Japan induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 China induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 India induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Australia induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Thailand induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 South Korea induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Latin America induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Brazil induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Argentina induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 MEA induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 South Africa induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Saudi Arabia induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 UAE induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Kuwait induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Key company categorization
Fig. 76 Company market positioning
Fig. 77 Market participant categorization
Fig. 78 Strategy framework

Product Code: GVR-4-68039-549-7

Induced Pluripotent Stem Cells Production Market Growth & Trends:

The global induced pluripotent stem cells production market size is expected to reach USD 2.76 billion by 2030, registering a CAGR of 9.44% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021.

The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells to SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19.

Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed to obtain the pluripotency as that of ESCs. These iPSCs are proving to be an ethically uncomplicated alternative for research that involves ESCs. The derivation of the ESCs is associated with the destruction of an embryo at the blastocyte stage, which has led to a maximum number of ethical debates. However, induced pluripotent stem cells have solved the ethical issue over the destruction of human embryos in research by involving only the genetic reprogramming of somatic cells. This has propelled the market growth and resulted in numerous applications including drug discovery, disease modeling, toxicology testing, and many others. For instance, in August 2021, Fate Therapeutics announced the treatment of the first patient with FT819 during clinical trials. FT819 is an engineered CAR-T cell therapy that is derived from iPSCs. Also, the rising focus of the research community on exploring applications of induced pluripotent stem cells in regenerative medicine due to their unique characteristics such as differential potential, self-renewable, immunomodulatory properties, and others; is set to drive the market expansion.

Induced Pluripotent Stem Cells Production Market Report Highlights:

By process, the manual iPSC production process segment dominated the market and accounted for the largest revenue share in 2023.
By workflow, the cell culture segment dominated the market with the largest revenue share of 37.34% in 2023. Cell culture workflow is inclusive of revenues generated from iPSC harvest products, expansion products, and differentiation products; thus contributing to the market relevance of this segment.
By product, the consumables and kits segment dominated the market and accounted for the largest revenue share of 40.32% in 2023. The never-ceasing research and development activities in the iPSCs space are driving the demand for various consumables & kits.
By application, drug development & discovery segment dominated the market with the largest revenue share of 43.33% in 2023.
By end-user, the biotechnology and pharmaceutical companies segment dominated the market with the largest revenue share of 59.35% in 2023. The availability and adoption of various kits, consumables, and instruments along with iPSCs products are driving the revenue generation in this segment.
North America dominated the market and accounted for the largest revenue share of 40.98% in 2023. The growing incidence of chronic diseases in this region, developed healthcare infrastructure, funds from private & government initiatives, and strategic business models are driving the revenue generation in the marketspace.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Process
- 1.2.2. Workflow
- 1.2.3. Product
- 1.2.4. Application
- 1.2.5. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Growing applications of regenerative medicine
  - 3.2.1.2. Technological advancements in ipsc production
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Stringent process control and regulatory challenges
  - 3.2.2.2. High cost of production
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Induced Pluripotent Stem Cells Production Market: Process Business Analysis

4.1. Technology Segment Dashboard
4.2. Global Induced Pluripotent Stem Cells Production Market Process, Movement Analysis
4.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Process, 2018 to 2030 (USD Million)
4.4. Manual iPSC Production Process
- 4.4.1. Global Manual iPSC Production Process Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Automated iPSC Production Process
- 4.5.1. Global Automated iPSC Production Process Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Induced Pluripotent Stem Cells Production Market: Workflow Business Analysis

5.1. Workflow Segment Dashboard
5.2. Global Induced Pluripotent Stem Cells Production Market Workflow Movement Analysis
5.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Reprogramming
- 5.4.1. Global Reprogramming Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Cell Culture
- 5.5.1. Global Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Cell Characterization/Analysis
- 5.6.1. Global Cell Characterization/Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Engineering
- 5.7.1. Global EngineeringMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Others
- 5.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Induced Pluripotent Stem Cells Production Market: Product Business Analysis

6.1. Product Segment Dashboard
6.2. Global Induced Pluripotent Stem Cells Production Market Product Movement Analysis
6.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
6.4. Instrument/Devices
- 6.4.1. Global Instrument/Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Automated Platforms
- 6.5.1. Global Automated Platforms Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Consumables & Kits
- 6.6.1. Global Consumables & Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. Media
  - 6.6.2.1. Global Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. Kits
  - 6.6.3.1. Global Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. Others
  - 6.6.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Services
- 6.7.1. Global Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Induced Pluripotent Stem Cells Production Market: Application Business Analysis

7.1. Sample Type Segment Dashboard
7.2. Global Induced Pluripotent Stem Cells Production Market Application Movement Analysis
7.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.4. Drug Development and Discovery
- 7.4.1. Global Drug Development and Discovery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Regenerative Medicine
- 7.5.1. Global Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Toxicology Studies
- 7.6.1. Global Toxicology Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Others
- 7.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Induced Pluripotent Stem Cells Production Market: End Use Business Analysis

8.1. End Use Segment Dashboard
8.2. Global Induced Pluripotent Stem Cells Production Market End Use Movement Analysis
8.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Research & Academic Institutes
- 8.4.1. Global Research & Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Biotechnology & Pharmaceutical Companies
- 8.5.1. Global Biotechnology & Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Hospitals & Clinics
- 8.6.1. Global Hospitals & Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Induced Pluripotent Stem Cells Production Market: Regional Estimates & Trend Analysis by Process, Workflow, Product, Application, & End Use

9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
9.3. North America
- 9.3.1. North America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.2. U.S.
  - 9.3.2.1. Key Country Dynamics
  - 9.3.2.2. Competitive Scenario
  - 9.3.2.3. Regulatory Framework
  - 9.3.2.4. U.S. Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.3. Canada
  - 9.3.3.1. Key Country Dynamics
  - 9.3.3.2. Competitive Scenario
  - 9.3.3.3. Regulatory Framework
  - 9.3.3.4. Canada Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.4. Mexico
  - 9.3.4.1. Key Country Dynamics
  - 9.3.4.2. Competitive Scenario
  - 9.3.4.3. Regulatory Framework
  - 9.3.4.4. Mexico Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Europe
- 9.4.1. Europe Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. UK
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Competitive Scenario
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. UK Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Germany
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Competitive Scenario
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. Germany Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. France
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Competitive Scenario
  - 9.4.4.3. Regulatory Framework
  - 9.4.4.4. France Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.5. Italy
  - 9.4.5.1. Key Country Dynamics
  - 9.4.5.2. Competitive Scenario
  - 9.4.5.3. Regulatory Framework
  - 9.4.5.4. Italy Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.6. Spain
  - 9.4.6.1. Key Country Dynamics
  - 9.4.6.2. Competitive Scenario
  - 9.4.6.3. Regulatory Framework
  - 9.4.6.4. Spain Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.7. Denmark
  - 9.4.7.1. Key Country Dynamics
  - 9.4.7.2. Competitive Scenario
  - 9.4.7.3. Regulatory Framework
  - 9.4.7.4. Denmark Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.8. Sweden
  - 9.4.8.1. Key Country Dynamics
  - 9.4.8.2. Competitive Scenario
  - 9.4.8.3. Regulatory Framework
  - 9.4.8.4. Sweden Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.9. Norway
  - 9.4.9.1. Key Country Dynamics
  - 9.4.9.2. Competitive Scenario
  - 9.4.9.3. Regulatory Framework
  - 9.4.9.4. Norway Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Asia Pacific
- 9.5.1. Asia Pacific Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Japan
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Competitive Scenario
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Japan Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. China
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Competitive Scenario
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. China Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. India
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Competitive Scenario
  - 9.5.4.3. Regulatory Framework
  - 9.5.4.4. India Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. Australia
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Competitive Scenario
  - 9.5.5.3. Regulatory Framework
  - 9.5.5.4. Australia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Thailand
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Competitive Scenario
  - 9.5.6.3. Regulatory Framework
  - 9.5.6.4. Thailand Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. South Korea
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Competitive Scenario
  - 9.5.7.3. Regulatory Framework
  - 9.5.7.4. South Korea Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Latin America
- 9.6.1. Latin America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. Brazil
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Competitive Scenario
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. Brazil Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. Argentina
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Competitive Scenario
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. Argentina Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.7. MEA
- 9.7.1. MEA Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.2. South Africa
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Competitive Scenario
  - 9.7.2.3. Regulatory Framework
  - 9.7.2.4. South Africa Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.3. Saudi Arabia
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Competitive Scenario
  - 9.7.3.3. Regulatory Framework
  - 9.7.3.4. Saudi Arabia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.4. UAE
  - 9.7.4.1. Key Country Dynamics
  - 9.7.4.2. Competitive Scenario
  - 9.7.4.3. Regulatory Framework
  - 9.7.4.4. UAE Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.5. Kuwait
  - 9.7.5.1. Key Country Dynamics
  - 9.7.5.2. Competitive Scenario
  - 9.7.5.3. Regulatory Framework
  - 9.7.5.4. Kuwait Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Participant Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Participant's Overview
- 10.4.1. Lonza
  - 10.4.1.1. Overview
  - 10.4.1.2. Financial Performance
  - 10.4.1.3. Product Benchmarking
  - 10.4.1.4. Strategic Initiatives
- 10.4.2. Axol Bioscience Ltd.
  - 10.4.2.1. Overview
  - 10.4.2.2. Financial Performance
  - 10.4.2.3. Product Benchmarking
  - 10.4.2.4. Strategic Initiatives
- 10.4.3. Evotec
  - 10.4.3.1. Overview
  - 10.4.3.2. Financial Performance
  - 10.4.3.3. Product Benchmarking
  - 10.4.3.4. Strategic Initiatives
- 10.4.4. REPROCELL Inc.
  - 10.4.4.1. Overview
  - 10.4.4.2. Financial Performance
  - 10.4.4.3. Product Benchmarking
  - 10.4.4.4. Strategic Initiatives
- 10.4.5. STEMCELL Technologies
  - 10.4.5.1. Overview
  - 10.4.5.2. Financial Performance
  - 10.4.5.3. Product Benchmarking
  - 10.4.5.4. Strategic Initiatives
- 10.4.6. Merck KGaA
  - 10.4.6.1. Overview
  - 10.4.6.2. Financial Performance
  - 10.4.6.3. Product Benchmarking
  - 10.4.6.4. Strategic Initiatives
- 10.4.7. Fate Therapeutics
  - 10.4.7.1. Overview
  - 10.4.7.2. Financial Performance
  - 10.4.7.3. Product Benchmarking
  - 10.4.7.4. Strategic Initiatives
- 10.4.8. Thermo Fisher Scientific, Inc.
  - 10.4.8.1. Overview
  - 10.4.8.2. Financial Performance
  - 10.4.8.3. Product Benchmarking
  - 10.4.8.4. Strategic Initiatives
- 10.4.9. Catalent, Inc
  - 10.4.9.1. Overview
  - 10.4.9.2. Financial Performance
  - 10.4.9.3. Product Benchmarking
  - 10.4.9.4. Strategic Initiatives
- 10.4.10. Applied StemCells, Inc.
  - 10.4.10.1. Overview
  - 10.4.10.2. Financial Performance
  - 10.4.10.3. Product Benchmarking
  - 10.4.10.4. Strategic Initiatives

人工多能性幹細胞生産の市場規模、シェア、動向分析レポート：プロセス別、ワークフロー別、製品別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030

人工多能性幹細胞生産市場の成長と動向：

人工多能性幹細胞生産市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブ概要

第3章市場の変数、動向、範囲

第4章人工多能性幹細胞生産市場：プロセスビジネス分析

第5章人工多能性幹細胞生産市場：ワークフロービジネス分析

第6章人工多能性幹細胞生産市場：製品ビジネス分析

第7章人工多能性幹細胞生産市場：用途ビジネス分析

第8章人工多能性幹細胞生産市場：最終用途ビジネス分析

第9章人工多能性幹細胞生産市場：プロセス、ワークフロー、製品、用途、最終用途別の地域推定・動向分析

第10章競合情勢

第11章アナリストの視点

List of Tables

List of Figures

Induced Pluripotent Stem Cells Production Market Growth & Trends:

Induced Pluripotent Stem Cells Production Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Induced Pluripotent Stem Cells Production Market: Process Business Analysis

Chapter 5. Induced Pluripotent Stem Cells Production Market: Workflow Business Analysis

Chapter 6. Induced Pluripotent Stem Cells Production Market: Product Business Analysis

Chapter 7. Induced Pluripotent Stem Cells Production Market: Application Business Analysis

Chapter 8. Induced Pluripotent Stem Cells Production Market: End Use Business Analysis

Chapter 9. Induced Pluripotent Stem Cells Production Market: Regional Estimates & Trend Analysis by Process, Workflow, Product, Application, & End Use

Chapter 10. Competitive Landscape

Chapter 11. Analyst View

人工多能性幹細胞生産の市場規模、シェア、動向分析レポート：プロセス別、ワークフロー別、製品別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030

人工多能性幹細胞生産市場の成長と動向：

人工多能性幹細胞生産市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブ概要

第3章 市場の変数、動向、範囲

第4章 人工多能性幹細胞生産市場：プロセスビジネス分析

第5章 人工多能性幹細胞生産市場：ワークフロービジネス分析

第6章 人工多能性幹細胞生産市場：製品ビジネス分析

第7章 人工多能性幹細胞生産市場：用途ビジネス分析

第8章 人工多能性幹細胞生産市場：最終用途ビジネス分析

第9章 人工多能性幹細胞生産市場：プロセス、ワークフロー、製品、用途、最終用途別の地域推定・動向分析

第10章 競合情勢

第11章 アナリストの視点

List of Tables

List of Figures

Induced Pluripotent Stem Cells Production Market Growth & Trends:

Induced Pluripotent Stem Cells Production Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Induced Pluripotent Stem Cells Production Market: Process Business Analysis

Chapter 5. Induced Pluripotent Stem Cells Production Market: Workflow Business Analysis

Chapter 6. Induced Pluripotent Stem Cells Production Market: Product Business Analysis

Chapter 7. Induced Pluripotent Stem Cells Production Market: Application Business Analysis

Chapter 8. Induced Pluripotent Stem Cells Production Market: End Use Business Analysis

Chapter 9. Induced Pluripotent Stem Cells Production Market: Regional Estimates & Trend Analysis by Process, Workflow, Product, Application, & End Use

Chapter 10. Competitive Landscape

Chapter 11. Analyst View

第1章調査手法と範囲

第2章エグゼクティブ概要

第3章市場の変数、動向、範囲

第4章人工多能性幹細胞生産市場：プロセスビジネス分析

第5章人工多能性幹細胞生産市場：ワークフロービジネス分析

第6章人工多能性幹細胞生産市場：製品ビジネス分析

第7章人工多能性幹細胞生産市場：用途ビジネス分析

第8章人工多能性幹細胞生産市場：最終用途ビジネス分析

第9章人工多能性幹細胞生産市場：プロセス、ワークフロー、製品、用途、最終用途別の地域推定・動向分析

第10章競合情勢

第11章アナリストの視点